5 – Quality (CMC) considerations
115 Quality (CMC) considerations Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical TrialsCelia Lourenco, PhD,Manager, Clinical Group IOffice of Clinical TrialsTherapeutic Products DirectorateL1Slide 1L1 Lourenco; : the information within this presentation is based on the presenter's expertise and experience, and represents the views of the presenter for the purposes of a training workshop3Overview Objective in the assessment of Quality CMC framework Summary of Quality (CMC)
1 5 – Quality (CMC) considerations Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD,
Download 5 – Quality (CMC) considerations
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Pine County, Drugs, Laws of trinidad and tobago, CENTRAL DRUGS STANDARD CONTROL, Central drugs standard control organization, List of drugs prohibited for manufacture, Sale through gazette notifications under section, Of drugs, The Regulation of Cosmetics in Japan, Controlled Substances Act, Controlled Substances